Insider filing · BBIO
Ole Andreas Halvorsen
10% owner
profile →
BridgeBio Pharma, Inc.
BBIO · Healthcare · 74 filings in 24 months
ticker →
Ole Andreas Halvorsen sold $154.0M of BridgeBio Pharma (BBIO)
Executed Jun 27 2025, disclosed Jul 1 2025, 4 days later.
Value, as filed
$154.0M
3,500,000 sh × $44.00
Executed
Jun 27 2025
the trade date, as filed
Disclosed
Jul 1 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
OHOle Andreas Halvorsen (10% owner) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $154.0M of BBIO (3,500,000 sh × $44.00, as filed), executed Jun 27 2025.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→